simple-beauty.css

Pharmaceutical facility design: adding value with construction technology and ‘Chip Thinking®'

2025-10-08 00:46:21

http://bit.ly/BWNewsUpdatesDesign for Manufacture and Assembly (DfMA).

With rising tuition costs and evolving industry demands, Satwinder supports expanding pathways into architecture, including apprenticeships and alternative degree models.Broadening access to the profession is essential for fostering innovation, diversity, and resilience in the next generation of architects..

Pharmaceutical facility design: adding value with construction technology and ‘Chip Thinking®'

This conversation with Satwinder Samra offers a thought-provoking exploration of architecture’s evolving role in society.From creating inclusive pathways for aspiring architects to redefining how we approach design and collaboration, Satwinder’s insights inspire us to envision a more accessible and impactful future for the built environment..Learn more about how we support personal and professional development at Bryden Wood.For pretty much forever, on-site or in-situ construction has been the default way of building.

Pharmaceutical facility design: adding value with construction technology and ‘Chip Thinking®'

However with accelerating interest in Design for Manufacture and Assembly (DfMA) and Modern Methods of Construction (MMC), it sometimes seems that on-site construction is falling out of favour..In 2019, the UK’s Ministry of Housing, Communities and Local Government (MHCLG) – as it was then called – published an MMC Definition Framework (see my earlier article,.

Pharmaceutical facility design: adding value with construction technology and ‘Chip Thinking®'

What does DfMA stand for?).

This framework proposes Pre-Manufactured Value (PMV) as a metric for assessing the scale of MMC adoption on a project.This is a time when we need to learn from nature and think hard about scale..

Going back to the rise of mammals or Homo sapiens, a change in scale is an adaptation to a transforming environment.This is arguably exactly where we are today with industrialisation – the ground is shifting quickly, fissures are opening up, lethal challenge and paths to opportunity are open to us like they were to our ancestors in the Rift Valley.

We need to be at the right scale to survive and prosper.. More in my next Blog….Professor John Dyson spent more than 25 years at GlaxoSmithKline, eventually ending his career as VP, Head of Capital Strategy and Design, where he focussed on developing a long-term strategic approach to asset management..